CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice

Journal of Immunology

Volumn 166, Issue 11, 2001, Pages 6972-6981

  Malmström, Vivianne ^a,c   Shipton, Deborah ^b   Singh, Baljit ^a   Al Shamkhani, Aymen ^b,d   Puklavec, Michael J ^b   Barclay, A Neil ^b   Powrie, Fiona ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD134L ANTIGEN; CELL ANTIGEN; INTEGRIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; ENTERITIS; IMMUNE DEFICIENCY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; MESENTERY LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

EID: 0035337241     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.11.6972     Document Type: Article

References (61)

1. Miller, R., and O. Stutman. 1984. T cell repopulation from functionally restricted splenic progenitors: 10,000-fold expansion documented by using limiting dilution analyses. J. Immunol. 133:2925.
2. Bell, E., S. Sparshott, M. Drayson, and W. Ford. 1987. The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells. J. Immunol. 139:1379.
3. Rocha, B., N. Dautigny, and P. Pereira. 1989. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immunol. 19:905.
4. Sakaguchi, S., T. Takahashi, and Y. Nishizuka. 1982. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirements of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156:1577.
5. low subset. J. Exp. Med. 172:1701.
6. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.
7. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J. Immunol. 162:3702.
8. + T cells. J. Exp. Med. 178:237.
9. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1461.
10. + T cells. Immunity 1:553.
11. Simpson, S. J., S. Shah, M. Comiskey, Y. P. de Jong, B. Wang, E. Mizoguchi, A. K. Bhan, and C. Terhorst. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J. Exp. Med. 187:1225.
12. + T cells. Am. J. Pathol. 148:1503.
13. + T-cells in the regulation of inflammatory responses in the intestine. Res. Immunol. 148:576.
14. high T cells to SCID recipients. J. Immunol. 158:3464.
15. Asseman, C., S. Mauze, M. Leach, R. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995.
16. + T cells. J. Exp. Med. 183: 2669.
17. (+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
18. + T cells inhibit both the induction and effector function of autoreactive T cells and represents a unique lineage of immunoregulatory cells. J. Immunol. 160:1212.
19. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J. Immunol. 155:1151.
20. Mason, D., and F. Powrie. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10:649.
21. Bretscher, P. 1999. A two-step, two-signal model for the primary activation of precursor T helper cells. Proc. Natl. Acad. Sci. USA 96:185.
22. Watts, T., and M. DeBenedette. 1999. T cell costimulatory molecules other than CD28. Curr. Opin. Immunol. 11:286.
23. Mallett, S., S. Fossum, and A. Barclay. 1990. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes: a molecule related to nerve growth factor receptor. EMBO J. 9:1063.
24. Gramaglia, I., A. Weinberg, M. Lemon, and M. Croft. 1998. OX40 ligand: a potent costimulator molecule for sustaining primary CD4 T cell responses. J. Immunol. 161:6510.
25. Baum, P., R. r. Gayle, F. Ramsdell, S. Srinivasan, R. Sorensen, M. Watson, M. Seldin, E. Baker, G. Sutherland, and K. Clifford. 1994. Molecular characterization of murine and human OX40/OX40 ligand system: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13:3992.
26. Al-Shamkhani, A., S. Mallett, M. Brown, W. James, and A. Barclay. 1997. Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis superfamily, and its receptor OX40 on activated T cells. J. Biol. Chem. 272:5275.
27. Stuber, E., M. Neurath, D. Calderhead, H. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic cells. Immunity 2:507.
28. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura. 1999. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:7058.
29. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159:3838.
30. Weinberg, A. D., K. W. Wegmann, C. Funatake, and R. H. Whitman. 1999. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1818.
31. Imura, A., T. Hori, K. Imada, T. Ishikawa, Y. Tanaka, M. Maeda, S. Imamura, and T. Uchiyama. 1996. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183:2185.
32. Stuber, E., and W. Strober. 1996. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:979.
33. Morimoto, S., Y. Kanno, Y. Tanaka, Y. Tokano, H. Hashimoto, S. Jacuot, C. Morimoto, S. F. Schlossman, H. Yagita, K. Okumura, and T. Kobata. 2000. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27 and CD134/CD134L interactions coordinately regulate T cell dependent B cell responses. J. Immunol. 164:4097.
34. Maxwell, J., A. Weinberg, R. Prell, and A. Vella. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107.
35. Pippig, S., C. Pena-Rossi, J. Long, W. Godfery, D. Fowell, S. Reiner, M. Birkeland, R. Locksley, A. Barclay, and N. Killeen. 1999. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163:6520.
36. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrange, B. Ecabert, B. Odermatt, and M. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11:699.
37. Chen, A., A. McAdam, J. Buhlmann, S. Scott, M. Lupher, E. Greenfield, P. Baum, W. Fanslow, D. Calderhead, G. Freeman, and A. Sharpe. 1999. Ox40-ligand has a critical costimulatory role in dendritic:T cell interactions. Immunity 11:689.
38. Murata, K., N. Ishii, H. Takano, S. Miura, L. C. Ndhlovu, M. Nose, T. Noda, and K. Sugamura. 2000. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191:365.
39. Stuber, E., A. von Freier, D. Marinescu, and U. R. Folsch. 1998. Involvement of OX40-OX40L interactions in the intestinal manifestations of the murine acute graft-versus-host disease. Gastroenterology 115:1205.
40. Higgins, L., S. McDonald, N. Whittle, N. Crockett, J. Shields, and T. MacDonald. 1999. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162:486.
41. Coffman, R. 1982. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:5.
42. Brown, M., K. Boles, P. van der Merwe, V. Kumar, P. Mathew, and A. Barclay. 1998. 2B4, the NK and T cell immunoglobulin superfamily surface protein is a ligand for CD48. J. Exp. Med. 188:2083.
43. Preston, S., G. Wright, K. Starr, and A. Barclay. 1997. The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur. J. Immunol. 27: 1911.
44. Weston, S., and C. Parish. 1990. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and flourescence microscopy. J. Immunol. Methods 133:87.
45. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565.
46. 7 integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur. J. Immunol. 21:2591.
47. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.
48. E on lymphocytes is not associated with mucosa-specific homing. Eur. J. Immunol. 25: 1487.
49. Saunders, D., K. Lucas, J. Ismaili, L. Wu, E. Maraskovsky, A. Dunn, and K. Shortman. 1996. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage-stimulating factor. J. Exp. Med. 184:2185.
50. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29:1610.
51. Matsumura, Y., T. Hori, S. Kawamata, A. Imura, and T. Uchiyama. 1999. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J. Immunol. 163: 3007.
52. Mackall, C., C. Bare, L. Granger, S. Sharrow, J. Titus, and R. Gress. 1996. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156:4609.
53. Beutner, U., and H. MacDonald. 1998. TCR-MHC class II interaction is required for peripheral expansion of CD4 cells in a T cell-deficient host. Int. Immunol. 10:305.
54. Freitas, A., and B. Rocha. 1999. Peripheral T cell survival. Curr. Opin. Immunol. 11:152.
55. Annacker, O., O. Burlen-Defranoux, R. Pimenta-Araujo, A. Cumano, and A. Bandeira. 2000. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J. Immunol. 164:3573.
56. MacPherson, G., S. Fossum, and B. Harrison. 1989. Properties of lymph-borne (veiled) dendritic cells in culture. II. Expression of the IL-2 receptor: role of GM-CSF. Immunology 68:108.
57. MacPherson, G., C. Jenkins, M. Stein, and C. Edwards. 1995. Endotoxin-mediated dendritic cell release from the intestine: characterization of released dendritic cells and TNF dependence. J. Immunol. 154:1317.
58. Lane, P. 2000. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J. Exp. Med. 191:201.
59. 7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 45:856.
60. + T cells. J. Immunol. 1558:2099.
61. + T cells by blocking the CD40-CD154 interactions. J. Immunol. 164:6005.